Janssen Promoted Risperdal Off Label, Jury Hears
Ortho-McNeil-Janssen Pharmaceuticals Inc. directed its salespeople to push the antipsychotic drug Risperdal for mood and behavioral disorders in children despite the risk male patients might grow breasts as a side effect,...To view the full article, register now.
Already a subscriber? Click here to view full article